Skip to main content

Table 1 Patient information

From: Comprehensive multiomics analysis reveals distinct differences between pediatric choroid plexus papilloma and carcinoma

Sample_ID

Age

Sex

Histology

Location

LMS

Survival

Overall survival (month)

Matched normal

TP53

EPHA7

RT-qPCR

(tissues)

F4/SF3

RT-qPCR

(cells)

F4/SF3

SNUH CPP 1

0 (8 m)

M

CPP

3V

−

Alive

99

N

  

√/√

 

SNUH CPP 2

2

M

CPP

LV

−

Alive

83

Y

  

√/√

 

SNUH CPP 3

2

M

CPP

4V

−

Alive

60

N

  

√/√

√/√

SNUH CPP 4

5

F

CPP

LV

−

Alive

55

N

  

√/√

 

SNUH CPP 5

5

F

CPP

4V

−

Alive

116

N

  

√/√

 

SNUH CPP 6

15

F

CPP

4V

−

Alive

52

Y

  

√/√

 

SNUH aCPP 1

0 (9 m)

F

aCPP

LV

−

Alive

60

Y

  

√/√

√/√

SNUH aCPP 2

16

F

aCPP

LV

−

Alive

133

N

  

√/−

 

SNUH mCPP 1

5

F

mCPP

LV

−

Alive

86

N

  

√/−

 

SNUH CPC 1

0 (4 m)

M

CPC

LV

−

Alive

5

Y

G

 

√/√

√/√

SNUH CPC 2

0 (10 m)

M

CPC

LV

 + 

Dead

7

Y

G

 

−/√

√/√

SNUH CPC 3

1

F

CPC

3V

 + 

Dead

14

Y

G

 

√/√

√/√

SNUH CPC 4

1

M

CPC

4V

 + 

Dead

9

Y

G

 

√/√

√/−

SNUH CPC 5

1

F

CPC

LV

−

Alive

137

N

 

G

√/√

 

SNUH CPC 6

2

F

CPC

LV

 + 

Unknown

16

N

G

 

√/√

 

SNUH CPC 7

5

M

CPC

LV

−

Alive

21

Y

G

 

√/√

 

SNUH CPC 8

9

M

CPC

4V

−

Alive

7

Y

S

 

√/√

√/−

SNUH CPC 9

9

F

CPC

LV

 + 

Dead

3

N

 

G

√/√

 

SNUH CPC 10

12

F

CPC

LV

−

Alive

34

Y

G

 

√/√

 

SNUH CPC 11

14

M

CPC

LV

−

Alive

87

Y

G

 

√/−

 
  1. CPP: choroid plexus papilloma, aCPP: atypical choroid plexus papilloma, mCPP: mixed choroid plexus papilloma and papillary ependymoma, CPC: choroid plexus carcinoma, M: male, F: female, LV: lateral ventricle, 3V: third ventricle, 4V: fourth ventricle, LMS: leptomeningeal seeding, overall survival (round to one decimal place), G: (real/predicted) germline mutation, S: (real/predicted) somatic mutation, F4: Fig. 4, SF3: Supplementary Fig. 3